Blonder Tongue Laboratories (BDR) Stock Price, News & Analysis

Company Overview

Blonder Tongue Laboratories, Inc. (NYSEAMERICAN: BDR) is a provider of broadband communications equipment and services, serving cable television, telecommunications, and broadband markets. Founded in 1950 and headquartered in Old Bridge, New Jersey, the company specializes in the design, manufacture, and distribution of headend and transmission components for video, data, and internet delivery. Over its history, Blonder Tongue has expanded its portfolio from analog modulation equipment to a comprehensive suite of digital video processing and fiber optic solutions.

The company’s product offerings include QAM and VSB modulators, encoders, combiners, amplifiers, optical nodes, and fiber optic transmitters and receivers. Its digital video processing line supports both MPEG-2 and MPEG-4 compression, while its DOCSIS-compliant cable modem termination systems and burst data over cable systems enable high-speed data and voice services. Blonder Tongue also manufactures video on demand systems and content delivery network solutions designed to optimize bandwidth utilization and improve signal reliability.

Blonder Tongue serves a diverse customer base that spans North America, Latin America, the Caribbean, and select markets in Europe and Asia. Its products are deployed by cable operators, system integrators, independent service providers, and private network operators. The company’s global distribution network and technical support capabilities enable it to address the needs of both large-scale operators and regional service providers, tailoring solutions to local infrastructure requirements.

Under the leadership of President and Chief Executive Officer Michael S. Zuk, Blonder Tongue has focused on innovation, strategic acquisitions, and operational efficiency. The management team emphasizes research and development to stay ahead of evolving industry standards such as DOCSIS 3.1 and IPTV protocols. With a commitment to expanding its digital and fiber product lines, Blonder Tongue aims to help its customers navigate the transition to all-digital, high-capacity networks.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 190,300 shs
• Average Volume: 364,033 shs
• Market Capitalization: $4.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BDR Stock Analysis - Frequently Asked Questions

How were Blonder Tongue Laboratories' earnings last quarter?

Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR) announced its earnings results on Friday, May, 15th. The technology company reported ($0.21) earnings per share (EPS) for the quarter. The technology company earned $4.05 million during the quarter. Blonder Tongue Laboratories had a negative net margin of 8.71% and a negative trailing twelve-month return on equity of 56.15%.

How do I buy shares of Blonder Tongue Laboratories?

Shares of BDR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Blonder Tongue Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Blonder Tongue Laboratories investors own include iBio (IBIO), VBI Vaccines (VBIV), Vaxart (VXRT), Nokia (NOK), Onconova Therapeutics (ONTX), Senseonics (SENS) and Agile Therapeutics (AGRX).

Company Calendar

• Last Earnings: 5/15/2020
• Today: 7/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Computer and Technology
• Industry: Radio & TV Communication Equipment
• Sub-Industry: N/A
• Current Symbol: NYSEAMERICAN:BDR
• CIK: 1000683
• Web: www.blondertongue.com
• Phone: (732) 679-4000
• Fax: 732-679-4353
• Employees: 85
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.47 million
• Net Margins: -8.71%
• Pretax Margin: -8.62%
• Return on Equity: -56.15%
• Return on Assets: -12.11%

Debt

• Debt-to-Equity Ratio: 0.41
• Current Ratio: 1.35
• Quick Ratio: 0.63

Sales & Book Value

• Annual Sales: $16.38 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.11 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 13,326,000
• Free Float: 5,337,000
• Market Cap: $4.06 million
• Optionable: Not Optionable
• Beta: 0.23